Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.99 - $2.91 $20,233 - $59,474
20,438 New
20,438 $24,000
Q2 2022

Aug 12, 2022

BUY
$1.54 - $6.48 $111,030 - $467,195
72,098 New
72,098 $111,000
Q1 2022

May 13, 2022

SELL
$3.67 - $7.63 $133,221 - $276,969
-36,300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.98 - $10.0 $180,774 - $363,000
36,300 New
36,300 $225,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.